Retrospective comparison of the clinical effects of oral semaglutide and SGLT2 inhibitors treatment in patients with type 2 diabetes.

J Diabetes Investig · 2026 · PMC12950920 · PMID 41555812

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceP = 0.18not close (p > 0.1)

showed a trendno p-value reported

The oral semaglutide group showed a trend of greater reduction in HbA1c for patients aged ≥ 65 years at 6 months, although the difference did not reach statistical significance (≥65 years; −0.80 ± 0.15%; <65 years; −1.22 ± 0.26%; P = 0.18; Figure 4a ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.